Increasing Incidence of Chronic Medical Conditions to Fuel Growth of Human Microbiome Market

human-microbiomeThe human microbiome also known as microbiota is composed of population of microbes such as fungi, bacteria and archaea. These microbes reside on the surface or in the deep layers of skin in oral mucosa, the saliva, gastrointestinal tracts and in the conjunctiva. At present, extensive research is being conducted to discover the importance of these micro-organisms in maintaining immune systems and contributing to digestion of food. Large number of microbes resides in the large intestine, with region of the human body having a distinct community of microbes dwelling. For instance, a specific microbial community prefers to grow on the skin or in the nose. Studies are still in progress to understand the factors regulating microbial colonization in areas of the body that are just millimeters apart. The Human Microbiome Project (HMP) was launched in 2008 as a U.S. National Institute of Health. This was initiated with a goal of identifying and characterizing the microbes found within the healthy and diseases human body.

The continuing advancement in biomedical sciences is likely to create opportunities for the application of human microbiome over the next few years. The increasing interest of leading players in mergers and acquisitions is expected to propel this market signifcanlty during the forecast period, notes the market study. In this report, the global market for human microbiome has been studied on the basis of disease, product, application, and region. Geographically, the worldwide market for human microbiome has been segmented into Europe, North America, Asia Pacific and the Rest of the World. North America and Europe have been leading the demand for human microbiome over the recent past and are expected to do so during the forecast period.

The continual improvement in the biotechnological and microbiological research infrastructure has been driving the growth of the human microbiome market in these regions since the last few years. Over the coming years, the mounting risk of lifestyle disorders is likely to propel this market in Europe and North America, states the research report.

Forthcoming Market Structure of Human Microbiome: http://bit.ly/2grcm1M

Based on disease, the report classifies the global market into autoimmune ailments, allergic conditions, diarrhea, obesity, cancer, diabetes, and various other diseases. Based on product, the market has been segmented into probiotics, prebiotics, drugs, devices, and medical foods. Furthermore, the medical food segment has been categorized into oral rehydration products, nutritionally complete formulae, nutritionally incomplete formulae, and formulae for metabolic disorders. Diagnostics and therapeutics have been identified as the two main application areas of human microbiome in this research study.

The leading players in the worldwide human microbiome market are ActoGenix, Enterome Bioscience SA, DuPont, Metabiomics Corp., MicroBiome Therapeutics LLC, Merck & Co. Inc., OptiBiotix Health Plc, Ritter Pharmaceuticals Inc., Osel Inc., Second Genome Inc., ViThera Pharmaceuticals Inc., Vedanta BioScience Inc., and Yakult Honsha Co. Ltd., states the report.

banner